Impressive potential with 30 to 40 mio new patients globally every year. No drugs currently available. Novel approach from NYR in this study. lf successful for humans, this drug can improve quality of life for an enormous amount of people and set NYR up for a market cap in the billions.
Ann: Significant Neuroprotection in NYR Preclinical Brain Injury, page-61
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.03M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1642 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 682527 | 2 |
View Market Depth
| Last trade - 07.10am 01/08/2025 (20 minute delay) ? |
| NYR (ASX) Chart |
Day chart unavailable